Synlett 2000; 2000(4): 550-552
DOI: 10.1055/s-2000-6564
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Deoxygenation of 5,12-Epoxy-5,12-dihydro-5,12-dimethyl-1,4-benzodioxino[2,3-g]isoquinoline with Iron Compounds. Synthesis of Antitumour Agents

Consol Bozzo* , M. Dolors Pujol
  • *Laboratori de Química Farmacèutica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; Fax +(93) 4 03 59 41; E-mail: mdpujol@farmacia.far.ub.es
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Fe2(CO)9 in benzene is effective in removing the oxygen from 5,12-epoxy-5,12-dihydro-5,12-dimethyl-1,4-benzodioxino[2,3-g]isoquinoline to give 5,12-dimethyl-1,4-benzodioxino[2,3-g]isoquinoline, an analogue of ellipticine, a known antitumour agent.

    >